|
Jun 26
|
DiaMedica Therapeutics Announces $11.8 Million Private Placement
|
|
Jun 26
|
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
|
|
May 28
|
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate
|
|
May 13
|
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript
|
|
May 8
|
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
|
|
May 2
|
DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
|
|
May 1
|
Bullish DiaMedica Therapeutics Insiders Loaded Up On US$15.7m Of Stock
|
|
Apr 18
|
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
|
|
Apr 17
|
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
|
|
Apr 15
|
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
|
Mar 25
|
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript
|
|
Mar 23
|
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
|
|
Mar 21
|
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) Path To Profitability
|
|
Mar 19
|
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
|
|
Jan 7
|
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%
|
|
Dec 4
|
Billionaire Lee Cooperman’s 10 Stock Picks with Huge Upside Potential
|
|
Nov 6
|
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
|
|
Jul 18
|
DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference
|